No Data
No Data
Insider Purchase: Director at $ABCL Buys 25,000 Shares
John Montalbano Bought 66% More Shares In AbCellera Biologics
Director Makes Bold Move With Major Stock Purchase in AbCellera Biologics
Bloom Burton Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Maintains Target Price $9
Analysts Have Conflicting Sentiments on These Healthcare Companies: Castle Biosciences (CSTL), AbCellera Biologics (ABCL) and Apellis Pharmaceuticals (APLS)
Benchmark Co. Maintains AbCellera Biologics(ABCL.US) With Hold Rating
Unlock the Full List
Buy n Die Together❤ :
73610841 : Adrian Nathaniel carter, I can’t tag him and we’re Facebook friends, does anyone know why?
Seth Beaty : Though you know if you bet against Cathie Wood, you’ll probably make money.
Rob banks : is there an ETF for this ai medical sector?
Chak : is it goid time yo
get into TEM ?
View more comments...